News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
84,460 Results
Type
Article (17081)
Company Profile (30)
Press Release (67338)
Multimedia
Podcasts (95)
Webinars (14)
Section
Business (30010)
Career Advice (913)
Deals (4710)
Drug Delivery (58)
Drug Development (8685)
Employer Resources (67)
FDA (1287)
Job Trends (2195)
News (39976)
Policy (2807)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (3)
2027 Genetown Elite (2)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (267)
Accelerated approval (11)
ADA (6)
Adcomms (17)
Allergies (30)
Alliances (7205)
ALS (52)
Alzheimer's disease (265)
Antibody-drug conjugate (ADC) (181)
Approvals (1113)
Artificial intelligence (237)
ASCO (61)
Autoimmune disease (96)
Automation (11)
Bankruptcy (61)
Belgium (2)
Best Places to Work (889)
BIO (40)
Biologics (3)
BIOSECURE Act (17)
Biosimilars (47)
BioSpace Insights (77)
Biotechnology (27)
Bispecific (1)
Bladder cancer (39)
Brain cancer (23)
Breast cancer (85)
Cancer (1151)
Cardiovascular disease (138)
Career advice (768)
Career pathing (33)
CAR-T (121)
CDC (6)
CDMO (86)
Cell therapy (305)
Cervical cancer (9)
Clinical research (7141)
Collaboration (691)
Commercialization (3)
Company closure (7)
Compensation (42)
Complete response letters (51)
COVID-19 (442)
CRISPR (29)
C-suite (484)
Cystic fibrosis (28)
Data (956)
Denatured (24)
Depression (49)
Dermatology (23)
Diabetes (64)
Diagnostics (572)
Digital health (5)
Diversity (4)
Diversity, equity & inclusion (19)
Drug discovery (155)
Drug pricing (50)
Drug shortages (1)
Duchenne muscular dystrophy (102)
Earnings (5487)
Editorial (40)
Employer branding (8)
Employer resources (69)
Events (11622)
Executive appointments (386)
FDA (1706)
Friedreich's ataxia (3)
Frontotemporal dementia (8)
Funding (628)
Gene editing (80)
Generative AI (28)
Gene therapy (317)
GLP-1 (281)
Government (507)
Grass and pollen (1)
Guidances (30)
Healthcare (1208)
Hematology (30)
HIV (13)
Huntington's disease (37)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (31)
Immunology and inflammation (170)
Immuno-oncology (45)
Indications (23)
Infectious disease (530)
Inflammatory bowel disease (42)
Inflation Reduction Act (3)
Influenza (25)
Intellectual property (50)
Interviews (142)
IPO (1745)
IRA (11)
Job creations (1136)
Job search strategy (672)
JPM (46)
Kidney cancer (5)
Labor market (80)
Layoffs (269)
Leadership (34)
Legal (709)
Licensing (7)
Liver cancer (11)
Longevity (11)
Lung cancer (147)
Lymphoma (61)
Machine learning (24)
Management (22)
Manufacturing (374)
MASH (50)
Medical affairs (1)
Medical device (376)
Medtech (382)
Mergers & acquisitions (3139)
Metabolic disorders (358)
mRNA (99)
Multiple sclerosis (24)
Multispecific (1)
NASH (7)
Netherlands (2)
Neurodegenerative disease (156)
Neuropsychiatric disorders (49)
Neuroscience (676)
Neurotech (1)
NextGen: Class of 2026 (895)
Non-profit (278)
Now hiring (56)
Obesity (217)
Opinion (215)
Ovarian cancer (30)
Pain (27)
Pancreatic cancer (52)
Parkinson's disease (66)
Partnered (14)
Patents (95)
Patient recruitment (110)
Peanut (5)
People (11314)
Peptides (2)
Pharmaceutical (8)
Phase 1 (2684)
Phase 2 (3428)
Phase 3 (2184)
Pipeline (1481)
Policy (153)
Postmarket research (114)
Preclinical (998)
Press Release (53)
Prostate cancer (40)
Psychedelics (48)
Radiopharmaceuticals (77)
Rare diseases (436)
Real estate (1508)
Recruiting (39)
Regulatory (2649)
Reports (19)
Research institute (301)
Resumes & cover letters (153)
Rett syndrome (5)
RNA editing (16)
RSV (19)
Schizophrenia (33)
Series A (150)
Series B (89)
Service/supplier (2)
Sickle cell disease (22)
Special edition (21)
Spinal muscular atrophy (19)
Sponsored (15)
Startups (1272)
Stomach cancer (6)
Supply chain (26)
Tariffs (36)
The Weekly (70)
Vaccines (297)
Venture capital (134)
Weight loss (151)
Women's health (30)
Worklife (12)
Date
Today (12)
Last 7 days (122)
Last 30 days (350)
Last 365 days (4867)
2026 (3497)
2025 (4836)
2024 (5162)
2023 (5104)
2022 (6183)
2021 (6460)
2020 (4991)
2019 (4065)
2018 (3346)
2017 (4120)
2016 (3749)
2015 (4168)
2014 (5704)
2013 (6400)
2012 (2420)
2011 (2485)
2010 (2076)
Location
Africa (275)
Alabama (12)
Alaska (2)
Arizona (51)
Arkansas (2)
Asia (7584)
Australia (1193)
California (1629)
Canada (645)
China (501)
Colorado (48)
Connecticut (57)
Delaware (73)
Europe (18388)
Florida (259)
Georgia (32)
Hawaii (1)
Idaho (5)
Illinois (70)
India (21)
Indiana (49)
Iowa (5)
Japan (139)
Kansas (11)
Kentucky (7)
Louisiana (4)
Maine (1)
Maryland (257)
Massachusetts (1408)
Michigan (26)
Minnesota (33)
Mississippi (1)
Missouri (24)
Montana (6)
Nebraska (4)
Nevada (25)
New Hampshire (3)
New Jersey (565)
New Mexico (6)
New York (455)
North Carolina (281)
North Dakota (1)
Northern California (738)
Ohio (60)
Oklahoma (8)
Oregon (7)
Pennsylvania (408)
Rhode Island (16)
South America (295)
South Carolina (5)
Southern California (696)
Tennessee (11)
Texas (254)
United States (5872)
Utah (45)
Virginia (28)
Washington D.C. (18)
Washington State (88)
West Virginia (1)
Wisconsin (27)
84,460 Results for "moleculin biotech".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Moleculin Biotech Reports Second Quarter 2026 Financial Results and Highlights Continued Advancement of Pivotal MIRACLE Trial
August 14, 2026
·
11 min read
Press Releases
Moleculin Presentation from H.C. Wainwright Conference Now Available On-Demand
September 11, 2026
·
4 min read
Press Releases
Moleculin Biotech Secures Strategic Additional Patent, Strengthening Global Positioning of Annamycin
May 8, 2026
·
5 min read
Press Releases
Moleculin’s MIRACLE R/R AML Trial Reports Positive Interim Data with 37% Blinded CRc in Venetoclax-Failed Patients
July 31, 2026
·
12 min read
Press Releases
Moleculin Announces Pricing of $9.3 Million Public Offering
August 2, 2026
·
5 min read
Press Releases
Moleculin CEO, Walter Klemp, Participates in the Virtual Investor “Why Now” On-Demand Conference
August 27, 2026
·
5 min read
Press Releases
Moleculin to Showcase New Annamycin Data at AACR Conference on Pancreatic Cancer and Two European Scientific Meetings
September 14, 2026
·
6 min read
Press Releases
Moleculin CEO, Walter Klemp, Highlights Positive Preliminary MIRACLE Trial Results in Virtual Investor “What This Means” Segment
July 6, 2026
·
4 min read
Press Releases
Moleculin’s Annamycin Extends Survival by More Than 60% in Metastatic Pancreatic Cancer Preclinical Models - Data Presented at AACR 2026
April 23, 2026
·
7 min read
Press Releases
Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control
June 30, 2026
·
9 min read
1 of 8,446
Next
